Compugen Valuation

CGEN Stock  ILA 556.70  14.20  2.49%   
At this time, the firm appears to be overvalued. Compugen shows a prevailing Real Value of 489.05 per share. The current price of the firm is 556.7. Our model approximates the value of Compugen from analyzing the firm fundamentals such as Current Valuation of 12.53 M, shares owned by insiders of 5.50 %, and Return On Equity of -0.44 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
556.70
Please note that Compugen's price fluctuation is very steady at this time. Calculation of the real value of Compugen is based on 3 months time horizon. Increasing Compugen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Compugen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Compugen Stock. However, Compugen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  556.7 Real  489.05 Hype  556.7 Naive  443.6
The real value of Compugen Stock, also known as its intrinsic value, is the underlying worth of Compugen Company, which is reflected in its stock price. It is based on Compugen's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Compugen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
485.45
Downside
489.05
Real Value
612.37
Upside
Estimating the potential upside or downside of Compugen helps investors to forecast how Compugen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Compugen more accurately as focusing exclusively on Compugen's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
438.08600.23762.37
Details
Hype
Prediction
LowEstimatedHigh
553.10556.70560.30
Details
Naive
Forecast
LowNext ValueHigh
440.00443.60447.20
Details

About Compugen Valuation

The stock valuation mechanism determines Compugen's current worth on a weekly basis. Our valuation model uses a comparative analysis of Compugen. We calculate exposure to Compugen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Compugen's related companies.
Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel, the United States, and Europe. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel. COMPUGEN operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 68 people.

8 Steps to conduct Compugen's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Compugen's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Compugen's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Compugen's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Compugen's revenue streams: Identify Compugen's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Compugen's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Compugen's growth potential: Evaluate Compugen's management, business model, and growth potential.
  • Determine Compugen's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Compugen's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Complementary Tools for Compugen Stock analysis

When running Compugen's price analysis, check to measure Compugen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compugen is operating at the current time. Most of Compugen's value examination focuses on studying past and present price action to predict the probability of Compugen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compugen's price. Additionally, you may evaluate how the addition of Compugen to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Global Correlations
Find global opportunities by holding instruments from different markets